arrow
M

Moataz A. Shaldam

kafr-elsheikh university
H指数:28
被引数:2,046

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthesis, Antibacterial Evaluation, and Chemometric Profiling of a Vanilloid-Based Compounds Library Active Against Helicobacter pylori

合成、抗菌活性评价及化学计量学分析:一种对幽门螺杆菌具有活性的香草醛基化合物库

2026-07-290
OA
Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP-1/EGFR Inhibitors

抗癌症的分子回旋镖:新型双PARP-1/EGFR抑制剂的分子设计、合成、生物评价及计算机模拟研究

2026-05-280
PRE
Design; synthesis; and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti-Mycobacterium tuberculosis agents

设计、合成及分子模拟新型噻唑并吡啶类烯酰基载体蛋白还原酶(InhA)抑制剂作为抗分枝杆菌药物

2026-04-170
PRE
Identification of isatin-triazole-benzenesulfonamide hybrids as dual hCA IX/XII and c-met inhibitors with hypoxia-mediated chemo-sensitizing activity

鉴定异噁唑-三唑-苯磺酰胺类杂合物作为具有缺氧介导化疗增敏活性的双重hCA IX/XII和c-met抑制剂

2025-10-060
PRE
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations

作为具有VEGFR-2抑制活性的抗增殖剂的新型磺酰胺系席夫碱: 合成,生物学评估和分子动力学模拟

2024-08-017
PRE
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
2024-08-0110
PRE
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles
2024-04-206
PRE
Rosuvastatin and diosmetin inhibited the HSP70/TLR4 /NF-KB p65/NLRP3 signaling pathways and switched macrophage to M2 phenotype in a rat model of acute kidney injury induced by cisplatin

瑞舒伐他汀和地osmetin抑制顺铂诱导的急性肾损伤大鼠HSP70/TLR4/nf-kb p65/NLRP3信号通路并将巨噬细胞转换为M2表型

2024-02-015
OAAI